New York State Common Retirement Fund Madrigal Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 40,815 shares of MDGL stock, worth $13.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40,815
Previous 46,445
12.12%
Holding current value
$13.6 Million
Previous $9.86 Million
27.77%
% of portfolio
0.02%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding MDGL
# of Institutions
303Shares Held
22MCall Options Held
819KPut Options Held
644K-
Janus Henderson Group PLC London, X02.48MShares$825 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$679 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$675 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$663 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$657 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.69B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...